Sage Therapeutics, Inc.

5493000JX4BJS9W6CN35

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: April 15, 2010

Address

Country: United States
Legal address: C/O The Corporation Trust Company19801 WilmingtonUnited States (US-DE)
Head office: 215 FIRST ST.02142 CambridgeUnited States (US-MA)

Identifier

LEI: 5493000JX4BJS9W6CN35
Registered: April 30, 2014 at 02:01 AM UTC
Last updated: April 10, 2024 at 01:30 PM UTC
Next renewal: April 9, 2024 at 05:49 PM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 4812455
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 4812455
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No parent prepares consolidated accounts including it

Machine access

REST: https://lei.online/v1/entities/5493000JX4BJS9W6CN35This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search